Authors: OLIVER S WINDFELD K HATORP V

Citation: S. Oliver et al., PHARMACOKINETICS AND BIOAVAILABILITY OF REPAGLINIDE, A NEW OHA FOR PATIENTS WITH NIDDM, Diabetes, 46, 1997, pp. 1263-1263

Authors: TRONIER B MARBURY TC DAMSBO P WINDFELD K

Citation: B. Tronier et al., A NEW ORAL HYPOGLYCEMIC AGENT, REPAGLINIDE MINIMIZES RISK OF HYPOGLYCEMIA IN WELL-CONTROLLED TYPE-2 DIABETIC-PATIENTS, Diabetes, 44, 1995, pp. 70-70